Document Detail


Intervention costs and cost-effectiveness for a multiple-risk-factor diabetes self-management trial for Latinas: economic analysis of ¡Viva Bien!
MedLine Citation:
PMID:  22081776     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Information on cost-effectiveness of multiple-risk-factor lifestyle interventions for Latinas with diabetes is lacking. The aim of this paper is to evaluate costs and cost-effectiveness for ¡Viva Bien!, a randomized trial targeting Latinas with type 2 diabetes. We estimated 6-month costs; calculated incremental costs per behavioral, biologic, and quality-of-life change; and performed sensitivity analyses from health plan and participant perspectives. Recruitment, intervention, and participant costs were estimated at $45,896, $432,433, and $179,697, respectively. This translates to $4,634 in intervention costs per ¡Viva Bien! participant; $7,723 in both per unit reduction in hemoglobin A1c and per unit reduction in body mass index. Although costs may be higher than interventions that address one risk factor, potential risks for longer-term health-care costs are high for this at-risk group. Given the benefits of ¡Viva Bien!, cost reductions are recommended to enhance its efficiency, adoption, and long-term maintenance without diluting its effectiveness.
Authors:
Debra P Ritzwoller; Anna S Sukhanova; Russell E Glasgow; Lisa A Strycker; Diane K King; Bridget Gaglio; Deborah J Toobert
Related Documents :
10171306 - Total quality management at bethesda, inc.
17193836 - Building the business case for clinical quality.
10260496 - Quality analysis in therapeutic recreation curricula.
22186386 - A prospective study of incidence and risk factors for the onset and persistence of low ...
8817296 - Superbugs: should antimicrobial resistance be included as a cost in economic evaluation?
16250626 - The office of strategy management.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Translational behavioral medicine     Volume:  1     ISSN:  1613-9860     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101554668     Medline TA:  Transl Behav Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  427-435     Citation Subset:  -    
Affiliation:
Institute for Health Research, Kaiser Permanente Colorado, P.O. Box378066, Denver, CO 80237-8066, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
R01 HL076151-05//NHLBI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Problem Stabilization: A Metric for Problem Improvement in Home Visiting Clients.
Next Document:  Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer.